II. Definitions
- Nephrostomy
- Surgery to precutaneously (via the skin) access the renal Pelvis
- Performed to drain urine in cases of obstructed outflow (e.g. Ureteral Stone), renal stone extraction, medication instillation or endoscopy
- Nephrostomy Tube
- Catheter tube placed between the skin and the renal Pelvis or calyx in order to drain urine (bypassing the ureter)
III. Indications: Nephrostomy Tube
- Urinary obstruction
- Urinary diversion
- Chemotherapy installation
- Endoscopy or other diagnostic testing
IV. Efficacy
- Successful placement in 99% of indicated cases
- Overall complication rate: <5%
V. Complications: Minor
- Skin entry site inflammation (redness, pain)
- Evaluate for localized Skin Infection
- Granulation tissue and scabbing is common around the insertion site and requires no management
- Consider irritation from adhesive dressing or from concentrated urine
- Change dressings frequently
- Consider Topical Antibiotic or skin protectants (e.g. aquaphor)
- Urine leak
- Evaluate for collection bag failure (check bag integrity and consider changing)
- Evaluate flange for decreased adhesion
- Remove hair around the skin anchoring site
- Decreased Urine Output
- Evaluate hydration status and fluid intake
- Evaluate tube for kinks and obstruction (see below)
- Evaluate capping applied to tube
- May also be affected by patient positioning (in relation to gravity)
VI. Complications: Tube Obstruction
- Causes
- Increased fluid viscosity
- Hypercalciuria
- Hyperuricosuria
- Differential Diagnosis
- Hematoma
- Abscess or other infection
- Kinked tube
- Dislodged Nephrostomy Tube
- Valve system incorrect setup
- Collection bag damage or dysfunction
- Management: Initial tube Flushing and irrigation attempt
- Disconnect Nephrostomy Tube from the collection bag using sterile technique
- Clean the Nephrostomy Tube tip with Alcohol or Chlorhexidine
- Draw 10 cc of sterile saline or sterile water into a syringe
- Attempt to gently flush the Nephrostomy Tube with syringe
- Disposition if tube obstruction cleared
- Discharge home with instructions for Nephrostomy Tube care and follow-up
- Management: Refractory Obstruction
- Consider differential diagnosis of tube obstruction (see above)
- Evaluation
- Complete Blood Count
- Basic metabolic panel
- Imaging with CT Abdomen and Pelvis with IV contrast (with or without renal Ultrasound)
- Specialty Consultation (Tube Placement Consultant: Intervention Radiology or Urology)
- Urgent Consultation if anuric or Acute Kidney Injury, or if patient Immunocompromised
VII. Complications: Tube Dislodged or Kinked
- Tubes dislodge in 5% of cases (esp. BMI >35 kg/m2)
- Findings
- Flank Pain or back pain
- Decreased Urine Output
- Nephrostomy site bleeding or urine leakage
- Presentation of a refractory tube obstruction that does not clear with tube Flushing
- Management
- If tube obstruction presentation, attempt initial management as above
- Obtain CT Abdomen and Pelvis with IV contrast to evaluate tube position
- Consult placing consultant for dislodged or kinked Nephrostomy Tube
VIII. Complications: Post-Nephrostomy Tube Infection (Pyonephrosis)
- Epidemiology
- Onset within first 6-7 weeks of tube placement in most cases
- Incidence of post-tube infection: <14%
- Asymptomatic Bacteriuria in 7.5% of cases
- Highest risk when purulent material aspirated during Nephrostomy Tube Placement
- Findings
- Systemic infection signs (e.g. fever, chills, Vital Sign changes)
- Sepsis and Septic Shock develops in as many as 60% of post-Nephrostomy infection patients
- Flank Pain or back pain
- Leukocytosis
- Urine changes (foul odor, Hematuria, decreased Urine Output)
- Systemic infection signs (e.g. fever, chills, Vital Sign changes)
- Causes
- Evaluation
- Complete Blood Count
- Basic chemistry panel
- Urinalysis and Urine Culture
- Obtain urine sample from Nephrostomy Tube (not the collection bag)
- Using sterile technique, detach collection bag, clean port with Alcohol swab
- Collect urine in sterile specimen cup (allowing drainage via gravity)
- Reconnect Nephrostomy Tube to a new collecting bag
- Anchor Nephrostomy Tube to prevent dislodgement
- Blood Cultures and Lactic Acid (if Sepsis)
- CT Abdomen and Pelvis with IV Contrast (if renal abscess or tube obstruction suspected)
- Management
- Initiate Antibiotics for acute, severe Pyelonephritis with catheter associated UTI
- Antibiotics should also cover MRSA if patient Sepsis
- Consult for tube exchange
IX. Complications: Bleeding or Hematuria
- Types
- Early Gross Hematuria (first 2-3 days)
- Common and expected post-operative bleeding following Nephrostomy Tube Placement
- Significant Hemorrhage occurs in up to 4 of patients
- Higher risk in patients with preoperative Renal Failure
- Delayed Hematoma or Hematuria (>2-3 days after tube placement)
- May present weeks to months after Nephrostomy Tube Placement
- Most commonly due to intraoperative vascular injury with secondary formation of AV fistula, Hematoma or pseudoaneurysm
- In significant blood loss and secondary Anemia, cardiopulmonary symptoms may be present (e.g. Tachycardia, Dyspnea, Syncope)
- Early Gross Hematuria (first 2-3 days)
- Evaluation (significant bleeding)
- Complete Blood Count
- Basic metabolic panel
- Urinalysis
- INR and PTT
- ABO Type and Screen
- Bedside Ultrasound (may demonstrate Hydronephrosis, Hematoma)
- CT Angiogram Abdomen
- Complications
- Tube Obstruction (Hematoma related)
- Acute Kidney Injury
- Anemia
- Management
- Manage Hemorrhagic Shock
- Specialty Consultation
- Angiograph with Embolization Indications
- Hemorrhagic Shock
- Increasing, refractory Hematuria
- Hematoma
X. Complications: Lung Injury (during placement)
- Complicates 0.3% of Nephrostomy Tube Placements
- Pneumothorax
- Hydrothorax
- Pleural Effusion
- Risk Factors
- Intercostal renal access between 11th and 12th ribs (higher risk than subcostal approach)
- Findings
- Decreased breath sounds
- Hypoxia
- Pleuritic Chest Pain
- Hypotension
XI. Resources
- Percutaneous Nephrostomy (Stat Pearls)
XII. References
- Long and Swaminathan in Swadron (2022) EM:Rap 22(10): 10-14
- Yoo (2021) Am J Emerg Med 50:592-6 +PMID: 34592566 [PubMed]